Skip to content

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

3rd Annual Gene Therapy for Ophthalmic Disorders


3rd October 2023 - 5 October, 2023


Boston, MA



The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting brings world class content, bringing two tracks of learning to tackle the pressing challenges faced in the pre-clinical stages and in clinical development. This includes challenges faces with drug targets including wet AMD, dry AMD, DME, IRDs and more.

Find out more

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox